PerkinElmer Launches VICTOR(R) Nivo(TM) Multimode Plate Reader

Food and Healthcare Press Releases Tuesday July 25, 2017 10:09
WALTHAM, Mass.--25 Jul--PRNewswire/InfoQuest
Multiple Detection Modes and Intuitive Software Help to Simplify and Accelerate Disease Research and Drug Discovery

PerkinElmer, Inc. , a global leader committed to innovating for a healthier world, announced on July 24 (US-time) the launch of its new VICTOR(R) Nivo(TM) multimode plate reader . Designed to fit almost any lab space, this compact, lightweight instrument provides high performance detection modes and easy-to-use software, which allows scientists to be able to accelerate biochemical and cell-based assays for disease research and drug development.

For the full multimedia release, click here: http://www.prnasia.com/mnr/perkinelmer_201707.shtml
https://photos.prnasia.com/prnvar/20170724/1903341-1-a
https://photos.prnasia.com/prnvar/20170724/1903341-1-b
https://photos.prnasia.com/prnvar/20170724/1903341-1-c

"In today's academic and pharmaceutical labs, scientists need intuitive, high performance technologies, including multimode microplate readers,   that can be applied to a broad range of applications to help advance their research," said Jim Corbett, Executive Vice President and President, Discovery & Analytical Solutions, PerkinElmer. "We offer a complete set of innovative solutions that are designed to help facilitate scientific breakthroughs."

"Multimode detection is an integral process in helping to advance our research," said Maria Kuzikov, Assay Development and Screening Specialist, Fraunhofer IME Screening Port in Germany, a PerkinElmer customer. "We have found that the VICTOR(R) Nivo(TM) multimode plate reader provides high performance for a broad range of biochemical and cell based applications including measuring cell proliferation and cytotoxicity, DNA and protein quantification, as well as characterization of compound effects on PDE activity. The reader is very easy to use so that even beginners can become productive quickly."

With a wide range of key detection modes, top and bottom reading for all modes and space for up to 32 filters, the instrument delivers high performance for cell-based and biochemical assays and can accommodate multiple users and applications. Its small, compact design helps researchers to maximize their lab resources, freeing up valuable bench space for other activities critical to the research process.

Scientists can control the instrument's software via Wi-Fi or network connection from a PC, laptop or tablet in order to effectively manage their workflows. The software's user interface makes it easy for novice scientists to quickly learn and navigate the instrument.

PerkinElmer offers a comprehensive portfolio of technologies to support life science research, including assay reagents, microplates, liquid handling/automation, and services. To learn more about the VICTOR Nivo multimode plate reader, visit www.perkinelmer.com/Nivo .

ABOUT PERKINELMER:

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Our dedicated team of 9,000 employees worldwide are passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics, discovery and analytical solutions markets. Our innovative detection, imaging, informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain earlier and more accurate insights to improve lives and the world around us.   The Company reported revenue of approximately $2.1 billion in 2016, serves customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com .

Follow us on Twitter @PKILifeScience .
Contact:
Samantha Pierce
+1-585-697-2606
perkinelmerdas@apcoworldwide.com

Latest Press Release

RSPO#s Continuous Commitment to Protecting Rainforests and Promoting Sustainable Consumption

The Roundtable on Sustainable Palm Oil (RSPO), in collaboration with a group of retailers, organized its campaign based on the theme of "Say Yes to Sustainable Palm Oil" in City Shop, Beijing on August 10th and later in Rainbow Shop, Shenzhen on August...

ACC Calls Upon Global Leaders To Take Action Against IARC Over Deliberate Manipulation Of Data

Cal Dooley, President and CEO of the American Chemistry Council (ACC) issued the following statement on the Reuters investigation into the International Agency for Cancer Research's (IARC) controversial Monograph 112. "Today's Reuters report...

The International Osteoporosis Foundation: Fractures due to Osteoporosis Threaten Seniors# Independence

It's invisible, and it's dangerous. Osteoporosis, which causes bones to become weak and fragile, only reveals itself when a bone breaks. (Photo: http://mma.prnewswire.com/media/582529/Osteoporosis.jpg ) In older adults that first 'fragility fracture'...

Merck Brings Customers Closer to Gene Therapy Product Commercialization

- Highlights position as leading contract manufacturing organization (CMO) for production of next-generation gene therapies Merck , a leading science and technology company, today announced that its Carlsbad, California-based manufacturing facility for...

Anpac Bio Surpasses 50,000 Case Study Milestone #Liquid Biopsy Pioneer# Serving Individual, Medical, Insurance Corporate Customers

Dr. Chris Yu, Chief Executive Officer of international life sciences corporation Anpac Bio-Medical Science Company , announced this week the company set a new, international record, processing and reporting over 50,000 cases worldwide of the company's...

Related Topics